AI-generated analysis. Always verify with the original filing.
Bioxytran, Inc. filed an 8-K on March 13, 2026, disclosing amendments to its Certificate of Designation of Convertible Preferred Stock and Certificate of Designation, approved by the Board, along with a performance-based equity award to an officer. These actions modify rights of security holders and involve compensatory arrangements for certain officers.
Event Type
Disclosure
Mandatory
Variant
8-K
Material Modification to Rights of Security Holders The Company approved and filed an amendment to the Certificate of Designation of Convertible Preferred Stock
Compensatory Arrangements of Certain Officers The Board of Directors of Bioxytran, Inc. (the “Company”) recently approved a performance-based equity award to Da
Amendments to Articles of Incorporation In connection with the amendment described above, the Company filed a Certificate of Amendment to the Certificate of Des
Exhibits 3.1 Certificate of Amendment to Certificate of Designation of Convertible Preferred Stock (Filed with the Nevada Secretary of State on February 18, 202